Sangui - Perle im Biotechsektor bald 1ooo % ? (Seite 1090)
eröffnet am 12.05.04 20:12:51 von
neuester Beitrag 26.03.24 17:06:19 von
neuester Beitrag 26.03.24 17:06:19 von
Beiträge: 79.773
ID: 859.129
ID: 859.129
Aufrufe heute: 1
Gesamt: 5.269.028
Gesamt: 5.269.028
Aktive User: 0
ISIN: US80105B1017 · WKN: 906757 · Symbol: SBH
0,0005
EUR
0,00 %
0,0000 EUR
Letzter Kurs 08:16:02 Hannover
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 6.300,00 | +4.940,00 | |
| 1,4600 | +34,94 | |
| 1,2300 | +24,24 | |
| 2,7600 | +20,00 | |
| 0,8000 | +19,40 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 21,600 | -20,00 | |
| 1,3800 | -20,80 | |
| 0,6700 | -26,58 | |
| 2,1300 | -34,41 | |
| 3,1600 | -38,64 |
Beitrag zu dieser Diskussion schreiben
Feedback
Antwort auf Beitrag Nr.: 47.685.192 von minadon am 03.09.14 16:53:38Na, das ist doch mal ein positives Lebenszeichen
Sehr geehrte Damen und Herren,
Im Anhang leiten wir Ihnen den aktuellen “Granulox Newsletter” der SastoMed GmbH zu Ihrer Kenntnisnahme weiter.
Mit freundlichen Grüßen
SanguiBioTech GmbH
________________________________
SanguiBioTech GmbH
Alfred-Herrhausen-Str. 44
58455 Witten
Tel.: +49 (0)2302 / 915 - 200
FAX +49 (0)2302 / 915 - 191
eMail: info@sangui.de
http://www.sangui.de
Geschäftsführer:
Hubertus Schmelz
Handelsregister:
Amtsgericht Bochum
HRB: 7986
Sitz: Witten
Umsatzsteuer Id:
DE 179 488 654
________________________________
Anfang der weitergeleiteten E‑Mail:
Newsletter September 2014
Dear Hubertus Schmelz,
New Granulox 6 ml Size
Now that we have received approval from the appropriate regulatory body, we are very pleased to introduce the Granulox 6 ml size to you. It is sufficient for 15 applications and therefore should last for about 6 weeks.
We appreciate your support in helping us evaluate its possibilities. As a result we see many opportunities for this new size: it's especially helpful for driving OTC sales, for a first purchase by sceptical customers and as samples for doctors in hospitals.
The Granulox 6 ml size will be available from now on. We'll provide you with all the relevant sales data in a separate mail and we're looking forward to receiving your first order soon.
Granulox - Frequency of Use change
Another piece of news we want to inform you about is the "Frequency of Use" change. Up to now the recommendation was to treat the wound with Granulox every day. The new Frequency of Use recommends an application every time the dressing is changed, but certainly at least every 3 days.
Next to a better implementation in actual practice, another big advantage is the positive effect on the weekly cost of patient care.
If you have any further questions regarding this or any other issue, please do not hesitate to contact us.
New video – The World of Granulox
We take great pleasure in presenting "Welcome to the World of Granulox", the signature of our brand new introductory promotional video.
"What great hopes we had for Granulox, this truly remarkable revolution in the long term healing of chronic wounds, in April 2012 as we began our first training sessions in Germany. And now, only 2 years later, we've found willing partners all over the world. People who have joined with us to bring Granulox rapidly to country after country. People like us who believe that in Granulox we have found the missing link to solve the age old problem of chronic wounds."
This is the message in our new video. But please look at it yourself. Just click on the link below. Of course, you'll surely want to download the video in order to share it with as many others as possible: by embedding it in your webpage, for presentations and for training.
This is the link to the video >>>
Best regards,
Michael Sander - CEO
Christin Gude – International Sales
Im Anhang leiten wir Ihnen den aktuellen “Granulox Newsletter” der SastoMed GmbH zu Ihrer Kenntnisnahme weiter.
Mit freundlichen Grüßen
SanguiBioTech GmbH
________________________________
SanguiBioTech GmbH
Alfred-Herrhausen-Str. 44
58455 Witten
Tel.: +49 (0)2302 / 915 - 200
FAX +49 (0)2302 / 915 - 191
eMail: info@sangui.de
http://www.sangui.de
Geschäftsführer:
Hubertus Schmelz
Handelsregister:
Amtsgericht Bochum
HRB: 7986
Sitz: Witten
Umsatzsteuer Id:
DE 179 488 654
________________________________
Anfang der weitergeleiteten E‑Mail:
Newsletter September 2014
Dear Hubertus Schmelz,
New Granulox 6 ml Size
Now that we have received approval from the appropriate regulatory body, we are very pleased to introduce the Granulox 6 ml size to you. It is sufficient for 15 applications and therefore should last for about 6 weeks.
We appreciate your support in helping us evaluate its possibilities. As a result we see many opportunities for this new size: it's especially helpful for driving OTC sales, for a first purchase by sceptical customers and as samples for doctors in hospitals.
The Granulox 6 ml size will be available from now on. We'll provide you with all the relevant sales data in a separate mail and we're looking forward to receiving your first order soon.
Granulox - Frequency of Use change
Another piece of news we want to inform you about is the "Frequency of Use" change. Up to now the recommendation was to treat the wound with Granulox every day. The new Frequency of Use recommends an application every time the dressing is changed, but certainly at least every 3 days.
Next to a better implementation in actual practice, another big advantage is the positive effect on the weekly cost of patient care.
If you have any further questions regarding this or any other issue, please do not hesitate to contact us.
New video – The World of Granulox
We take great pleasure in presenting "Welcome to the World of Granulox", the signature of our brand new introductory promotional video.
"What great hopes we had for Granulox, this truly remarkable revolution in the long term healing of chronic wounds, in April 2012 as we began our first training sessions in Germany. And now, only 2 years later, we've found willing partners all over the world. People who have joined with us to bring Granulox rapidly to country after country. People like us who believe that in Granulox we have found the missing link to solve the age old problem of chronic wounds."
This is the message in our new video. But please look at it yourself. Just click on the link below. Of course, you'll surely want to download the video in order to share it with as many others as possible: by embedding it in your webpage, for presentations and for training.
This is the link to the video >>>
Best regards,
Michael Sander - CEO
Christin Gude – International Sales
Antwort auf Beitrag Nr.: 47.682.918 von Roylander am 03.09.14 13:51:28sorry, hab mich verlesen....dort steht der 26.09. Ist aber auch von Bloomberg nur ein Schätzdatum aufgrund vergangener Berichte. Kommt aber meistens ungefähr hin. Die Zahlen sind ja aber bereits bekannt. Interessant wird es eher bei den ausgegebenen Aktien, da der Kurs so miserabel ist.
Antwort auf Beitrag Nr.: 47.682.813 von Neutralis am 03.09.14 13:41:18Danke! Dann warten wir halt noch ein wenig....
Trading Spotlight
Antwort auf Beitrag Nr.: 47.681.934 von Roylander am 03.09.14 12:27:03Lt. Bloomberg am 29.09. Es ist der Jahresbericht, deshalb haben die etwas länger Zeit.
Wann kommt der nächste Form 10K-Bericht? Müsste doch bald soweit sein. 
Genau! So isset. Super Beitrag.
Und wird diese, wenn es so weitergeht, bald auf 0 wertberichtigen muessen. Herzlichen Glueckwunsch, Herr Doktor.
Durchsuchen
Sangui - Perle im Biotechsektor bald 1ooo % ?
